Related Experiment Videos
[Alteration of p15 and p16 gene in gastric cancer]
S Fushida1, Y Yonemura, T Kawamura
1Second Dept. of Surgery, School of Medicine, Kanazawa University.
Abstract:
We analyzed p15 and p16 gene alterations in gastric cancer. Only MKN45 showed both homozygous deletions but other cell lines and all of tumor specimens did not show any alterations. Using RT-PCR analysis, decreased or no expression of the p16 gene was found in 1 of 7 cell lines (except MKN45) (14.2%) and in 8 of 20 tumors (40%), whereas no abnormalities of p15 gene expression were found. These results suggest that the p16 gene may correlate with tumorigenesis and tumor expansion due to decrease or loss of gene products in gastric cancer.
Insights
Altered p16 gene expression, not p15, is linked to gastric cancer development and growth. This suggests the p16 gene plays a role in tumorigenesis, with decreased or lost products potentially driving cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Context:
- Gastric cancer is a significant global health concern.
- Understanding the genetic underpinnings of gastric cancer is crucial for developing effective therapies.
- The roles of tumor suppressor genes, such as p15 and p16, are frequently investigated in various cancers.
Purpose:
- To investigate the alterations and expression patterns of the p15 and p16 genes in gastric cancer.
- To determine the potential correlation between p15/p16 gene status and gastric cancer development.
Summary:
- Analysis of gastric cancer cell lines and tumor specimens revealed homozygous deletions for p15 and p16 genes only in the MKN45 cell line.
- Reverse transcription-polymerase chain reaction (RT-PCR) analysis showed decreased or absent p16 gene expression in 14.2% of other cell lines and 40% of tumor samples.
- No abnormalities in p15 gene expression were detected, suggesting a specific role for p16 in gastric tumorigenesis.
Impact:
- The findings indicate that alterations in the p16 gene, specifically decreased or lost expression, may be associated with gastric cancer initiation and progression.
- This study highlights the potential of p16 as a biomarker or therapeutic target in gastric cancer.
- Further research into p16's functional role could lead to novel diagnostic and therapeutic strategies for gastric cancer patients.